SOPHIA Trial Outcomes

obr has 860 videos Subscribe Here

Description: Sara Tolaney, MD, Associate Director, Susan F. Smith Center for Women’s Cancers, Director Clinical Trials, Breast Oncology, Associate Professor of Medicine, Harvard Medical School provides an overview of the SOPHIA trial, a phase III of chemotherapy plus margetuximab or trastuzumab in HER+ metastatic breast cancer after pertuzumab with 1-3 prior lines of treatment.
Shared By : obr
Posted on : 07/02/19
Added : 15 days ago
Category : Breast Cancer